Routine use of pleural fluid cultures. Are they indicated?. Limited yield, minimal impact on treatment decisions

Respiratory Medicine

Volumn 100, Issue 11, 2006, Pages 2048-2052

  Jimenez D ^a,b   Diaz G ^c   Garcia Rull S ^a   Vidal, R ^a   Sueiro, A ^a,b   Light, R W ^d  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c Respiratory Department   (Spain)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Cultures; Drainage; Empyema; Gram stain; Parapneumonic effusions

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIAGNOSTIC VALUE; FEMALE; GRAM STAINING; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MALE; MEDICAL DECISION MAKING; MORTALITY; PLEURA EFFUSION; PLEURA FLUID; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; THORAX DRAINAGE; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; DRAINAGE; EMPYEMA, PLEURAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURA; PLEURAL EFFUSION; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33749368242     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.02.008     Document Type: Article

References (22)

1. Light R.W., Girard W.M., Jenkinson S.G., and George R.B. Parapneumonic effusions. Am J Med 69 (1980) 507-512
2. Colice G.L., Curtis A., Deslauriers J., et al. Medical and surgical treatment of parapneumonic effusions. Chest 18 (2000) 1158-1171
3. Light R.W. Useful tests on the pleural fluid in the management of patients with pleural effusions. Curr Opin Pulm Med 5 (1999) 245-249
4. Neiderman M.S., Bass J.B., Campbell G.D., Fein A.M., Grossman R.F., Mandell L.A., et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assesment of severity and initial antimicrobial therapy. Am Rev Respir Dis 148 (1993) 1418-1426
5. Frías J., Gomis M., Prieto J., Mensa E., Bouza E., García-Rodríguez J.A., et al. Tratamiento antibiótico empírico inicial de la neumonía adquirida en la comunidad. Rev Esp Quimioter 11 (1998) 255-261
6. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med 163 (2001) 1730-1754
7. Davies C.W.H., Kearney S.E., Gleeson F.V., and Davies R.J.O. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 160 (1999) 1682-1687
8. Poe R.H., Marin M.G., Israel R.H., and Kallay M.C. Utility of pleural fluid analysis in predicting tube thoracostomy/decortication in parapneumonic effusions. Chest 100 (1991) 963-967
9. Ferrer A., Osset J., Alegre J.M., et al. Prospective clinical and microbiological study of pleural effusions. Eur J Clin Microbiol Infect Dis 18 (1999) 237-241
10. Wait M.A., Sharma S., Hohn J., and Nogare A.D. A randomized trial of empyema therapy. Chest 111 (1997) 1548-1551
11. Fine M.J., Orloff J.J., Rihs J.D., et al. Evaluation of housestaff physicians' preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Intern Med 6 (1991) 189-198
12. Sahn S.A. Management of complicated parapneumonic effusions. Am Rev Respir Dis 148 (1993) 813-817
13. Waterer G.W., Jennings S.G., and Wunderink R.G. The impact of blood cultures on antibiotic therapy in pneumococal pneumonia. Chest 116 (1999) 1278-1281
14. Lieberman D., Schlaeffer F., Boldur I., et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 51 (1996) 179-184
15. Mundy L.M., Oldach D., Auwaerter P.G., et al. Implications for macrolide treatment in community-acquired pneumonia. Chest 113 (1998) 1201-1206
16. Alfageme I., Muñoz F., Peña N., and Umbría S. Empyema of the thorax in adults: etiology, microbiologic findings and management. Chest 99 (1993) 1162-1165
17. Smith J.A., Mullerworth M.H., Westlake G.W., and Tatoulis J. Empyema thoracis: 14-year experience in a teaching center. Ann Thorac Surg 51 (1991) 39-42
18. Sanyal S., Smith P.R., Saha A.C., et al. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am J Respir Crit Care Med 160 (1999) 346-348
19. Waterer G.W., and Wunderink R.G. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 95 (2001) 78-82
20. Torres A., Serra-Batlles J., Ferrer A., et al. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 144 (1991) 312-318
21. Lorey O., Georges H., Beuscart C., et al. Severe community-acquired pneumonia in ICU's: prospective validation of prognostic score. Intensive Care Med 22 (1996) 1307-1314
22. Barnes T.W., Olson E.J., Morgenthaler T.I., Edson R.S., Decker P.A., and Ryu J.H. Low yield of microbiological studies on pleural fluid specimens. Chest 127 (2005) 916-921